Skip to main content
search
All Posts By

Ben Kemp

Membership NewsMembership News Archive

Rare Diseases Action Plan: Briefing

Last week marked the release of the Government’s Rare Diseases Action Plan for 2024. The Plan looks at the achievements in tackling rare diseases over the previous year and establishes future goals to enable fundamental change. This is the third iteration of England’s plan, having been published annually since 2022. Pertaining to the diagnosis of rare diseases, the Government listed…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

MHRA MedTech Regulatory Reform Webinar: Briefing

The MHRA yesterday outlined planned significant updates to UK Medical Device Regulations. The changes include updating the scope of the Regulations, changing the classification of in-vitro diagnostics devices (IVD) and change the Essential Requirements. The definition of 'in-vitro diagnostic devices' will now include software and devices intended for diagnosing physical or mental impairments, predispositions to medical conditions or diseases, and…
Ben Kemp
March 6, 2024
ConsultationsConsultations Archive

Addition of quadruple test to Edwards’ syndrome screening pathway

The UK National Screening Committee (UK NSC) endorses the offer of antenatal screening for Edwards’ syndrome as part of the NHS fetal anomaly screening pathway. The UK NSC is consulting on a rapid review of modelled data conducted by NHS England. This data suggests that the quadruple screening test, which is offered to pregnant women who miss the first trimester combined screening test, should be…
Ben Kemp
February 21, 2024
HighlightsHighlights Archive

Media Monitoring: 15 – 21 February

Understanding the lived-experience and support-needs of people living with antimicrobial resistance in the UK through interpretative phenomenological analysis An important examination of the effects of AMR on patients In the UK nearly 54,000 infections were caused by serious resistant bacteria in 2022 Emerging evidence indicates that patients lack an understanding of what AMR is, yet they also report significant psychological…
Ben Kemp
February 21, 2024
HighlightsHighlights Archive

New project to ‘unlock prevention’ within ICSs

The NHS Confederation, University of Stirling, University of Southampton and Newton have launched a research project to understand the barriers to unlocking at-scale preventative health and care within integrated care systems (ICSs). The research will map prevention work being undertaken at system, place and neighbourhood levels and the barriers that exist to collaborative prevention. The research team, professors Paul Cairney…
Ben Kemp
February 21, 2024
HighlightsHighlights Archive

DNA analysis could explain increased risk of prostate cancer in Black men

Scientists have discovered genetic differences which explain why Black men are more prone to prostate cancer compared to other ethnicities, leading to hopes that a test can be developed which identifies those at elevated risk. Prostate cancer is the most prevalent form of cancer among men in Britain, accounting for approximately 52,300 cases and 12,000 fatalities annually in the UK.…
Ben Kemp
February 21, 2024
Membership NewsMembership News Archive

NHS Navigation Day, 21st March 2024

Are you a HealthTech SME or innovator looking to navigate the NHS? Join this Navigation Day to obtain insight into the NHS, and the fundamentals for scaling your HealthTech venture including: - NHS Landscape: Understand the structure of the NHS and healthcare - Regulatory Environment: ‘Is my technology a medical device?’ - Health Economics: An introduction to economic evaluation of health innovations - NHS Business Cases: What you…
Ben Kemp
February 21, 2024
Membership NewsMembership News Archive

Pioneering genetic biobank to start recruiting patients on stroke prevention medicines

The pioneering Yellow Card Biobank, a pilot launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, has begun investigating a new group of medicines used to prevent strokes known as Direct Oral Anticoagulants. The Yellow Card Biobank aims to help understand how a patient’s genetic makeup can impact the safety of their medicines and forms part of…
Ben Kemp
February 21, 2024
Close Menu